Masami Iida

Author PubWeight™ 6.74^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Chemical chaperone therapy: clinical effect in murine G(M1)-gangliosidosis.	Ann Neurol	2007	0.93
2	Enzyme enhancement activity of N-octyl-beta-valienamine on beta-glucosidase mutants associated with Gaucher disease.	Biochim Biophys Acta	2007	0.89
3	Fibroblast screening for chaperone therapy in beta-galactosidosis.	Brain Dev	2006	0.88
4	Microscale preparation of even- and odd-numbered N-acetylheparosan oligosaccharides.	Carbohydr Res	2005	0.85
5	Chemical chaperone therapy: chaperone effect on mutant enzyme and cellular pathophysiology in β-galactosidase deficiency.	Hum Mutat	2011	0.85
6	Therapeutic chaperone effect of N-octyl 4-epi-β-valienamine on murine G(M1)-gangliosidosis.	Mol Genet Metab	2012	0.82
7	Lysosomal accumulation of Trk protein in brain of GM₁ -gangliosidosis mouse and its restoration by chemical chaperone.	J Neurochem	2011	0.79
8	Chemical chaperone therapy: luciferase assay for screening of β-galactosidase mutations.	Mol Genet Metab	2010	0.75
9	The pharmacological chaperone effect of N-octyl-beta-valienamine on human mutant acid beta-glucosidases.	Blood Cells Mol Dis	2009	0.75
10	The effect of N-octyl-β-valienamine on β-glucosidase activity in tissues of normal mice.	Brain Dev	2010	0.75